Literature DB >> 33646520

Impact of COVID-19 on workload burden of a complex radiotherapy facility.

Giulio Francolini1,2, Isacco Desideri3, Giulia Stocchi3, Lucia Pia Ciccone3, Viola Salvestrini3, Pietro Garlatti3, Michele Aquilano3, Daniela Greto4, Pierluigi Bonomo4, Icro Meattini4,3, Vieri Scotti4, Silvia Scoccianti4, Gabriele Simontacchi4, Lorenzo Livi3.   

Abstract

BACKGROUND AND
PURPOSE: COVID-19 constitutes a worldwide threat, prompting Italian Government to implement specific measures on March 8, 2020, to protect patients and health workers from disease transmission. The impact of preventive measures on daily activity of a radiotherapy facility may hamper the ability to fulfill normal workload burden. Thus, we assessed the number of delivered treatments in a specific observation period after the adoption of preventive measures (since March 11 to April 24, 2020) and compared it with the corresponding period of the year 2019.
MATERIALS AND METHODS: Overall number of delivered fractions was related to actual time of platform daily activity and reported as a ratio between number of delivered fractions and activity hours (Fr/Hrs). Fr/Hrs were calculated and compared for two different periods of time, March 11-April 24, 2019 (Fr/Hrs1), and March 11-April 24, 2020 (Fr/Hrs2).
RESULTS: Fr/Hrs1 and Fr/Hrs2 were 2.66 and 2.54 for year 2019 and 2020, respectively, for a Fr/Hrsratio of 1.07 (95% CI 1.03-1.12, p = 0.0005). Fr/Hrs1 was significantly higher than Fr/Hrs2 for SliR and PreciseR, with Fr/Hrsratio of 1.92 (95% CI 1.66-2.23, p < 0.0001) and 1.11 (95% CI 1.03-1.2, p = 0.003), respectively. No significant difference was reported for SynergyR and CyberknifeR with Fr/Hrsratio of 0.99 (95% CI 0.91-1.08, p = 0.8) and 0.9 (95% CI 0.77-1.06, p = 0.2), respectively. Fr/Hrs1 was significantly lower than Fr/Hrs2 for TomotherapyR, with Fr/Hrsratio of 0.88 (95% CI 0.8-0.96, p = 0.007).
CONCLUSION: Preventive measures did not influence workload burden performed. Automation in treatment delivery seems to compensate effectively for health workers number reduction.

Entities:  

Year:  2021        PMID: 33646520      PMCID: PMC7917169          DOI: 10.1007/s11547-021-01338-8

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  9 in total

1.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.

Authors:  Graziano Onder; Giovanni Rezza; Silvio Brusaferro
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

2.  COVID-19: Generate and apply local modelled transmission and morbidity effects to provide an estimate of the variation in overall relative healthcare resource impact at general practice granularity.

Authors:  Mike Stedman; Mark Lunt; Mark Davies; Martin Gibson; Adrian Heald
Journal:  Int J Clin Pract       Date:  2020-06-23       Impact factor: 2.503

3.  Risk of COVID-19 for patients with cancer.

Authors:  Yang Xia; Rui Jin; Jing Zhao; Wen Li; Huahao Shen
Journal:  Lancet Oncol       Date:  2020-03-03       Impact factor: 41.316

Review 4.  Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres.

Authors:  Riccardo Campi; Daniele Amparore; Umberto Capitanio; Enrico Checcucci; Andrea Salonia; Cristian Fiori; Andrea Minervini; Alberto Briganti; Marco Carini; Francesco Montorsi; Sergio Serni; Francesco Porpiglia
Journal:  Eur Urol       Date:  2020-04-11       Impact factor: 20.096

Review 5.  Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints-Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States.

Authors:  Lior Z Braunstein; Erin F Gillespie; Linda Hong; Amy Xu; Samuel F Bakhoum; John Cuaron; Boris Mueller; Beryl McCormick; Oren Cahlon; Simon Powell; Atif J Khan
Journal:  Adv Radiat Oncol       Date:  2020-04-01

6.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.

Authors:  Wenhua Liang; Weijie Guan; Ruchong Chen; Wei Wang; Jianfu Li; Ke Xu; Caichen Li; Qing Ai; Weixiang Lu; Hengrui Liang; Shiyue Li; Jianxing He
Journal:  Lancet Oncol       Date:  2020-02-14       Impact factor: 41.316

7.  The official French guidelines to protect patients with cancer against SARS-CoV-2 infection.

Authors:  Benoit You; Alain Ravaud; Anne Canivet; Gérard Ganem; Philippe Giraud; Rosine Guimbaud; Laure Kaluzinski; Ivan Krakowski; Didier Mayeur; Thomas Grellety; Jean-Pierre Lotz
Journal:  Lancet Oncol       Date:  2020-03-25       Impact factor: 41.316

Review 8.  Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic.

Authors:  Christopher J D Wallis; Giacomo Novara; Laura Marandino; Axel Bex; Ashish M Kamat; R Jeffrey Karnes; Todd M Morgan; Nicolas Mottet; Silke Gillessen; Alberto Bossi; Morgan Roupret; Thomas Powles; Andrea Necchi; James W F Catto; Zachary Klaassen
Journal:  Eur Urol       Date:  2020-05-03       Impact factor: 20.096

9.  Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists.

Authors:  Icro Meattini; Pierfrancesco Franco; Liliana Belgioia; Luca Boldrini; Angela Botticella; Maria Carmen De Santis; Giulia Marvaso; Giampaolo Montesi; Silvana Parisi; Luca Triggiani; Matteo Lambertini; Lorenzo Livi
Journal:  ESMO Open       Date:  2020-04
  9 in total
  5 in total

Review 1.  Management of cutaneous melanoma: radiologists challenging and risk assessment.

Authors:  Vincenza Granata; Igino Simonetti; Roberta Fusco; Sergio Venanzio Setola; Francesco Izzo; Luigi Scarpato; Vito Vanella; Lucia Festino; Ester Simeone; Paolo Antonio Ascierto; Antonella Petrillo
Journal:  Radiol Med       Date:  2022-07-14       Impact factor: 6.313

2.  Imaging Severity COVID-19 Assessment in Vaccinated and Unvaccinated Patients: Comparison of the Different Variants in a High Volume Italian Reference Center.

Authors:  Vincenza Granata; Roberta Fusco; Alberta Villanacci; Simona Magliocchetti; Fabrizio Urraro; Nardi Tetaj; Luisa Marchioni; Fabrizio Albarello; Paolo Campioni; Massimo Cristofaro; Federica Di Stefano; Nicoletta Fusco; Ada Petrone; Vincenzo Schininà; Francesca Grassi; Enrico Girardi; Stefania Ianniello
Journal:  J Pers Med       Date:  2022-06-10

3.  Pulmonary Lymphangitis Poses a Major Challenge for Radiologists in an Oncological Setting during the COVID-19 Pandemic.

Authors:  Roberta Fusco; Igino Simonetti; Stefania Ianniello; Alberta Villanacci; Francesca Grassi; Federica Dell'Aversana; Roberta Grassi; Diletta Cozzi; Eleonora Bicci; Pierpaolo Palumbo; Alessandra Borgheresi; Andrea Giovagnoni; Vittorio Miele; Antonio Barile; Vincenza Granata
Journal:  J Pers Med       Date:  2022-04-12

4.  Impact on mental health of the COVID-19 pandemic in a radiation oncology department.

Authors:  Morena Caliandro; Gregucci Fabiana; Alessia Surgo; Roberta Carbonara; Maria Paola Ciliberti; Ilaria Bonaparte; Sergio Caputo; Alba Fiorentino
Journal:  Radiol Med       Date:  2022-01-16       Impact factor: 6.313

Review 5.  Covid-19 and radiotherapy: a systematic review after 2 years of pandemic.

Authors:  Antonio Piras; Valeria Venuti; Andrea D'Aviero; Davide Cusumano; Stefano Pergolizzi; Antonino Daidone; Luca Boldrini
Journal:  Clin Transl Imaging       Date:  2022-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.